The redirection of healthcare and life sciences resources to COVID-19 has taken focus from other areas of need, including antimicrobial resistance.
Jamie Culp
Advertisement
Articles by Jamie Culp
Advertisement
Latest Updated Articles
COVID and AMR: Crisis Reframes Antibiotics FightDecember 11th 2020
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Enspryng (Satralizumab) for Thyroid Eye Disease
2
EMA Panel Backs Lilly’s Foundayo for Obesity and Type 2 Diabetes in Europe
3
AstraZeneca Taps insitro AI for MASH in Deal Worth Up to $1.5 Billion
4
The Bubble You Don’t Know You’re In: A Three-Part Series on The Medical Benefit Bubble
5